Archives
Stiripentol, LDH, and Lactate Flux in Epilepsy
2026-08-22
Explore how Stiripentol, a noncompetitive LDH inhibitor, can be used to interrogate lactate flux, astrocyte-neuron lactate shuttle modulation, and seizure biology. This article translates recent histone lactylation findings into practical assay decisions while distinguishing established evidence from testable research hypotheses.
NIID Patient iPSC Model with NOTCH2NLC Expansion
2026-08-21
This resource study establishes HZSMHCi002-A, a patient-derived induced pluripotent stem cell line carrying a GGC repeat expansion in the 5′ untranslated region of NOTCH2NLC, a major genetic cause of neuronal intranuclear inclusion disease. The line provides a characterized starting point for modeling NIID cellular pathology and testing future interventions, while its single-donor design and lack of gene correction define important limits for interpretation.
Nintedanib: ATRX-Stratified Research Design
2026-08-20
Nintedanib (BIBF 1120) is a triple angiokinase inhibitor suited to mechanism-driven angiogenesis and tumor studies. This article develops an ATRX-stratified assay framework that connects receptor tyrosine kinase biology with practical decisions about controls, endpoints, exposure, and translational limits.
SGI-1027: A DNMT Inhibitor for Smarter Cancer Assays
2026-08-20
SGI-1027 is a DNA methyltransferase inhibitor that connects DNMT biochemistry with more rigorous cancer-cell response assays. This guide explains how to distinguish growth inhibition from cell killing when evaluating DNA methylation inhibition and tumor suppressor gene reactivation.
Sisomicin Workflows for Antibacterial Research
2026-08-19
Build more informative Sisomicin studies by pairing broth susceptibility with time-kill, intracellular, and exposure–response designs. This workflow helps distinguish direct antibacterial activity from cell penetration, inoculum, resistance, and pharmacokinetic effects across Gram-negative and Gram-positive models.
RG7388: Reliable MDM2 Antagonist Assays
2026-08-19
Learn how RG7388 (MDM2 antagonist, oral, selective), SKU A3763, can improve the design and interpretation of biochemical, viability, proliferation, and apoptosis assays. This scenario-based guide connects p53 biology with practical solvent, dosing, control, and vendor-selection decisions.
Halazone and Sodium Current Inactivation in Frog Nerves
2026-08-18
The reference study used voltage-clamped frog nerve fibers to compare Halazone and related chemical reagents as probes of sodium-current inactivation. Its contrasting reagent responses weakened the case for a uniquely essential methionine residue and instead supported a cautious membrane-lipid explanation, while also defining important limits for translating neurophysiological findings to water disinfection or antimicrobial resistance research.
EZ Cap™ Cy5 EGFP mRNA: A Two-Clock Assay
2026-08-18
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) separates cellular uptake from productive translation through Cy5 and EGFP signals. This article presents a morphology-aware framework for interpreting mRNA delivery data and designing more decisive gene regulation studies.
Nintedanib: An ATRX-Aware Research Framework
2026-08-17
Nintedanib (BIBF 1120) offers a powerful way to study coordinated VEGFR, FGFR, and PDGFR signaling. This article presents an ATRX-aware assay framework that separates direct tumor-cell vulnerability from vascular and stromal effects.
β-Elemene Inhibits Adipogenesis via AMPK
2026-08-17
The reference study identifies β-Elemene as an inhibitor of MDI-induced adipogenesis in 3T3-L1 cells and connects this effect with restoration of AMPK-pathway activity. Its in vitro design provides a useful framework for examining lipid accumulation, insulin resistance, glucose handling, and signaling responses, while leaving in vivo efficacy and molecular target validation for future work.
Anti Reverse Cap Analog for Synthetic mRNA
2026-08-16
Learn how orientation-specific 5′ capping can improve synthetic mRNA translation, from in vitro transcription setup to cell-reprogramming workflows. Practical parameters, assay choices, and troubleshooting guidance connect ARCA chemistry with transgene-free oligodendrocyte differentiation research.
AI-10-49 Workflow for CBFβ-SMMHC Inhibition
2026-08-15
AI-10-49 connects direct CBFβ-SMMHC–RUNX1 dissociation with chromatin, transcriptional, viability, and animal-model readouts. This mechanism-led workflow helps distinguish selective target engagement from nonspecific leukemia cell toxicity in acute myeloid leukemia research.
Recombinant Human Oncostatin M: Assay Workflows
2026-08-14
Build more reproducible cytokine stimulation, proliferation, and release assays with tag-free, E. coli–expressed rh-Oncostatin M. This guide translates findings on CXCL1-CXCR2-driven neuroinflammation into practical, hypothesis-generating assay designs without conflating OSM biology with the reference pathway.
SB-3CT Workflows for MMP-9 and ECM Assays
2026-08-14
SB-3CT is a mechanism-based gelatinase inhibitor for separating MMP-2 and MMP-9 activity in extracellular-matrix, tumor, and neural models. This workflow-focused guide covers dosing logic, PNN assay design, matrix handling, and troubleshooting for reproducible preclinical experiments.
Dabigatran Etexilate: From Prodrug to Assay
2026-08-13
Dabigatran etexilate is an oral prodrug and direct thrombin inhibitor with important implications for translational coagulation research. This guide focuses on how prodrug activation, assay selection, and matrix choice shape interpretable thrombin-inhibition data.
610 records 11/41 page Previous Next First page 上5页 1112131415 下5页 Last page